Anthem Subsidiary to Trial Remote Monitoring Platform
CareMore Health System, a wholly owned subsidiary of Anthem Blue Cross, will conduct an investigation into the effectiveness of remote patient monitoring technology in reducing hospital readmissions.
CareMore Health System, a wholly owned subsidiary of Anthem Blue Cross, will conduct an investigation into the effectiveness of remote patient monitoring technology in reducing hospital readmissions.
CareMore, based in Cerritos, Calif., is the parent company of multiple health plans that operate under three federally approved Medicare Advantage contracts. The CareMore subsidiaries serve a total of more than 80,000 Medicare members in California, Nevada, and Arizona.
The system has selected an integrated remote patient monitoring and analytics service from Sentrian for the study. The Sentrian platform is designed to prevent avoidable hospitalization by leveraging remote biosensors and machine learning to remotely detect deterioration in patients' health before it becomes acute.
The initial implementation is focused on patients with chronic obstructive pulmonary disease and other concomitant conditions. A large controlled study with 1,000 CareMore members and another 1,000 members who are not on the platform as a control group will be developed to measure the effectiveness of the Sentrian RPI service in reducing preventable hospitalization.
"Sentrian goes beyond our previous attempts at remote patient monitoring by providing a personalized view into the unique patterns of individual patients, comparing their current metrics with their medical history, their baseline vitals, caregiver and family observations, and longitudinal health information," said David Ramirez, M.D., chief quality officer of CareMore. "We expect the technology will both make a difference in our patients' lives and enable us to scale our care management program quickly as we expand into more states in the near future."
Sentrian and CareMore expect to publish the results of the pilot study later this year.
CareMore, based in Cerritos, Calif., is the parent company of multiple health plans that operate under three federally approved Medicare Advantage contracts. The CareMore subsidiaries serve a total of more than 80,000 Medicare members in California, Nevada, and Arizona.
The system has selected an integrated remote patient monitoring and analytics service from Sentrian for the study. The Sentrian platform is designed to prevent avoidable hospitalization by leveraging remote biosensors and machine learning to remotely detect deterioration in patients' health before it becomes acute.
The initial implementation is focused on patients with chronic obstructive pulmonary disease and other concomitant conditions. A large controlled study with 1,000 CareMore members and another 1,000 members who are not on the platform as a control group will be developed to measure the effectiveness of the Sentrian RPI service in reducing preventable hospitalization.
"Sentrian goes beyond our previous attempts at remote patient monitoring by providing a personalized view into the unique patterns of individual patients, comparing their current metrics with their medical history, their baseline vitals, caregiver and family observations, and longitudinal health information," said David Ramirez, M.D., chief quality officer of CareMore. "We expect the technology will both make a difference in our patients' lives and enable us to scale our care management program quickly as we expand into more states in the near future."
Sentrian and CareMore expect to publish the results of the pilot study later this year.
More for you
Loading data for hdm_tax_topic #better-outcomes...